Growth Funding Conavi Medical recently secured multiple financing milestones including $10 million in equity funding and a $1.25 million milestone payment, signaling stronger capital availability and potential for accelerated R&D and commercial expansion in image guidance technologies.

U.S. Expansion Plans to expand offices to the United States by October 2026, paired with FDA clearance of a next-generation hybrid imaging system, create a clear sales pathway for direct U.S. market entry and accelerated adoption among interventional Cardiovascular procedures.

Strategic Partnerships Recent engagement with PwC as auditors and active participation in industry events and investment summits indicate an emphasis on governance, credibility, and networking; leverage these relationships to access potential channels, pilots, and OEM collaborations.

Clinical Focus Targeting minimally invasive cardiovascular procedures with image guidance positions Conavi at the intersection of evolving clinical trends; identify hospital systems and cardiovascular centers undergoing capital upgrades seeking cost-effective imaging solutions and workflow integration.

Leadership & Expertise Appointment of a seasoned CFO and a clear push toward commercialization suggests readiness to scale; sales teams can align with finance-stage milestones for multi-year procurement planning and budget cycles in medtech.